Repository logo
 
Publication

The Impact of Multidisciplinary Team Conferences in Urologic Cancer in a Tertiary Hospital

2021-01Journal article Open access
Simple item page
dc.contributor.authorGil, M
dc.contributor.authorGuerra, J
dc.contributor.authorAndrade, V
dc.contributor.authorMedeiros, M
dc.contributor.authorGuimarães, T
dc.contributor.authorBernardino, R
dc.contributor.authorFalcão, G
dc.contributor.authorCalais da Silva, F
dc.contributor.authorCampos Pinheiro, L
dc.date.accessioned2021-08-02T13:38:34Z
dc.date.available2021-08-02T13:38:34Z
dc.date.issued2021-01
dc.description.abstractPurpose: Multidisciplinary team (MDT) conferences are currently the standard of care in cancer patients' management. Despite evidence supporting benefits to the majority of malignancies, a paucity of data exists examining the impact in urinary and male genital cancers. This study aims to evaluate the impact of MDT conferences in urologic cancer practice. Methods: Clinical plans discussed in urologic MDT conferences in Centro Hospitalar Universitário de Lisboa Central between January 2019 and December 2019 were retrospectively analysed. Clinical plans were categorized as accepted, changed, rejected (cases that had to be re-presented to the MDT because of insufficient staging or administrative issues) or no plan. MDT conferences' impact was assessed according to type of consultation, referral medical specialty and primary tumour type. Results: 710 clinical plans were discussed at the MDT conferences. 61.8% were accepted, 10.6% were changed, 16.5% were rejected and 11.1% of cases referred to MDT discussion had no defined clinical plan. First consultations had a higher rate of accepted clinical plans (63.4%) versus subsequent consultations (56.4%). Referrals by the urology specialty had the highest rate of acceptances (64.3%). On the stratification by primary tumour site, testicular cancer had the highest acceptance rate (70.3%), whereas bladder cancer had the lowest (47.8%). Conclusions: MDT conferences had an important impact in the management of 38.2% of cases. Therefore, all patients with urologic malignancies should be referred to MDT review to ensure optimal clinical care.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationInt Urol Nephrol. 2021 Jan;53(1):41-47.pt_PT
dc.identifier.doi10.1007/s11255-020-02608-6pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/3784
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerpt_PT
dc.subjectAgedpt_PT
dc.subjectAged, 80 and overpt_PT
dc.subjectFemalept_PT
dc.subjectHumanspt_PT
dc.subjectMalept_PT
dc.subjectMiddle Agedpt_PT
dc.subjectRetrospective Studiespt_PT
dc.subjectTertiary Care Centerspt_PT
dc.subjectUrologic Neoplasmspt_PT
dc.subjectCongresses as Topicpt_PT
dc.subjectPatient Care Teampt_PT
dc.subjectPractice Patterns, Physicians'pt_PT
dc.subjectUrologypt_PT
dc.subjectCHLC UROpt_PT
dc.titleThe Impact of Multidisciplinary Team Conferences in Urologic Cancer in a Tertiary Hospitalpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage47pt_PT
oaire.citation.issue1pt_PT
oaire.citation.startPage41pt_PT
oaire.citation.titleInternational Urology and Nephrologypt_PT
oaire.citation.volume53pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Int Urol Nephrol 2021 41.pdf
Size:
425.3 KB
Format:
Adobe Portable Document Format
Download

Collections

URO - Artigos